Sanofi Asks 340B Hospitals for Information on Purchases of Its Top-Selling Drug

Sanofi is reportedly asking hospitals for data relating to 340B purchases of Dupixent.
French drugmaker Sanofi has reportedly asked some hospitals for data relating to 340B purchases of a popular drug used to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

Drug Industry-funded Think Tank Raises Questions About 340B Hospitals’ Charity Care

The Pioneer Institute for Public Policy Research compared 29 financially strong 340B hospitals/health systems’ performance on charity care in an Aug. 19 brief.
More transparency surrounding 340B hospital operations is needed to ensure drug discount savings are being used to improve patient care, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

AHA Raises ‘Serious Concerns’ with MedPAC’s Direction on 340B

American Hospital Association logo
AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”
A major hospital advocacy group recently urged congressional advisers to “carefully consider” the potential negative consequences of any new efforts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

GSK Announces Refunds for 340B Overcharges

GlaxoSmithKline will refund covered entities that purchased certain formulations of a severe asthma treatment in 2022.
GlaxoSmithKline (GSK) will refund covered entities that purchased certain formulations of a severe asthma treatment medication in the third quarter [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

340B ESP Updates Claims Submission Policy, Stakeholders Voice Concerns About Compliance

Second Sight Solutions updated 340B ESP's terms of use on Oct. 4.
340B covered entities could soon be required to share new information—including reimbursement amounts, ship to dates and ship to locations—as [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

Former Pfizer Exec. Slams 340B, Says IRA Will Worsen Program in New Op-Ed 

Kirsten Axelsen, a consultant and former Pfizer executive, cautioned that the 340B program “will be even worse” under the IRA in an Aug. 13 op-ed.
A former Pfizer executive and current biopharmaceutical consultant took aim this week at what she called the “poorly managed” 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

Massachusetts’ 340B Contract Pharmacy Access Bill Fails to Move in Formal Session, Stakeholders Remain Hopeful

A contract pharmacy access bill could still pass in Massachusetts despite the end of the formal legislative session.
Although Massachusetts lawmakers left Beacon Hill this month without passing a long-stalled 340B contract pharmacy access bill, provider groups say [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

Hospital-Backed Candidate Wins Missouri GOP Governor Primary Over Two Candidates Who Vowed to Repeal 340B Contract Pharmacy Access Law

Missouri Secretary of State Jay Ashcroft (R) shared a picture on X with Virginia Gov. Glenn Youngkin (R) at the Republican National Convention (RNC) last month praising the governor "for vetoing the 340b legislation that would fund abortions and benefits for illegals." Ashcroft lost his gubernatorial bid Tuesday.
A state hospital-backed candidate won Tuesday’s Missouri Republican gubernatorial primary after defeating a high-profile opponent with dark money ties who [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

Private Oncologist Group-Funded Study Highlights 340B Contract Pharmacies’ Links to PBMs

Community Oncology Alliance released a study that tries to connect 340B contract pharmacy relationships to the PBM industry.
More than two-thirds of 340B contract pharmacies are associated with pharmacy benefit managers (PBMs) through either vertical integration or contractual [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »

Senate Committee Votes to Increase HRSA Funding, Flat Fund OPA and Chides Drug Manufacturers on 340B Restrictions

US Capitol
A Senate Committee recently approved the FY25 Departments of Labor, Health and Human Services, Education and Related Agencies Appropriations Act.
The Senate panel responsible for federal appropriations legislation overwhelmingly passed a bill last week that would increase funding for the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live